The effect of isradipine on maximal electroshock seizures in mice

General Pharmacology

Volumn 31, Issue 1, 1998, Pages 133-135

  Ozyazgan S ^a   Senses V ^a   Utkan, T ^b   Yildiran, ^b   Ulak, G ^b   Gacar, N ^b   Ozuner Z ^a   Akkan, A G ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b KOCAELI UNIVERSITY   (Turkey)

Author keywords

Isradipine; Maximal electroshock seizure; Mice

Indexed keywords

CALCIUM ANTAGONIST; CALCIUM CHANNEL; DIHYDROPYRIDINE DERIVATIVE; ISRADIPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ELECTRIC SHOCK; EPILEPTIC DISCHARGE; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE;

ANIMALS; ANTICONVULSANTS; BLOOD-BRAIN BARRIER; CALCIUM CHANNEL BLOCKERS; DRUG EVALUATION, PRECLINICAL; ELECTROSHOCK; FEMALE; ISRADIPINE; MALE; MICE; SEIZURES;

EID: 0032126598     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(97)00390-X     Document Type: Article

References (46)

1. Aghajanian G.K., Wang Y.Y. Pertussis toxin blocks the outward currents evoked by opiate and alpha-2-agonists in locus coeruleus neurons. Brain Res. 371:1986;390-394.
2. Akkan A.G., Yillar D.O., Eşkazan E., Akcasu A., Özüner Z. The effect of propranolol on maximal electroshock seizures in mice. Int. J. Clin. Pharmac. Ther. Toxicol. 27:1988;255-257.
3. Andrade R., Malenka R.C., Nicoll R.A. A G-protein couples serotonin and GABA-B receptors to the same channels in hippocampus. Science. 234:1986;1261-1265.
4. Ashton D., Wauquier A. Behavioral analysis of the effects of 15 anticonvulsants in the amygdaloid kindled rat. Psychopharmacology. 65:1979;7.
5. Carboni E., Wojcik W.J. Dihydropyridine binding sites regulate calcium influx through specific voltage-sensitive calcium channels in cerebral granule cells. J. Neurochem. 50:1988;1279-1286.
6. Davies J.D., Evans R.H., Francis A.A.et al. Conformational aspects of the actions of some piperidine dicarboxylic acids at excitatory amino acid receptors in the mammalian and amphibian spinal cords. Neurochem. Res. 7:1982;1119-1133.
7. De Sarro G.B., Meldrum B.S., Nistico G. Anticonvulsant effects of some calcium entry blockers in DBA/2 mice. Br. J. Pharmac. 93:1988;247.
8. Desmedt L.K.C., Niemegeers C.I.E., Kanssen B.A.J. Anticonvulsive properties of cinnarizine and flunarizine in rats and mice. Arzneim.-Forsch. Drug Res. 25:1975;1408.
9. Dolin S.J., Hunter A.B., Halsey M.J., Little H.J. Anticonvulsant profile of the dihydropyridine calcium channel antogonists, nitrendipine and nimodipine. Eur. J. Pharmac. 152:1988;19.
10. Eigyo M., Shiomi T., Inoue Y., Sakagushi I., Ishibashi C., Murata S., Koyabu K., Matsushita A., Adachi I. and Ueda M. (1994) Pharmacological studies on a new dihydrothienopyridine calcium antagonist, S-312-d, 5th communication: anticonvulsant effect in mice. Jpn. J.
11. Eşkazan E., Yillar D.O., Akcasu A., Akkan A.G. Nalokson'un findik farelerinde maksimal elektroşok nöbetine etkisi. Cerrahpaşa Tip Fak. Der. 21:1990;179-186.
12. Evart A. S. (1972) Electrically-induced convulsions. In Experimental Models of Epilepsy. A Manual for Laboratory Workers, p. 433. Raven Press, New York.
13. Gaggi R., Dall'Olio R., Roncada P., Gianni A.M. Effects of isradipine and darodipine on serotonergic system of the rat brain. Pharmac. Biochem. Behav. 51(2-3):1995;183-187. a.
14. Gaggi R., Dall'Olio R., Roncada P., Gianni A.M. Peculiar effects of isradipine and darodipine on the rat brain dopaminergic system. Gen. Pharmac. 26:1995;303-308. b.
15. Grenningloh G., Rienitz A., Schmitt B., Methfessel C., Zensen M., Beyreuther K., Gundelfinger E.D., Betz H. The strychnine-binding subunit of the glycine receptor shows homology with nicotinic acetylcoline receptors. Nature. 328:1987;215-220.
16. Gross R.A., MacDonald R.L. Barbiturates and nifedipine have different and selective effects on calcium currents of mouse DRG neurons in culture. a possible basis for differing clinical actions Neurology. 18:1987;443-451.
17. Gross R.A., Kelly K.M., MacDonald R.L. Ethosuximide and dimethidione selectively reduce calcium currents in cultured sensory neurons by different mechanisms. Neurology. 39:1989;412. (Suppl.)
18. + during pentetrazole-induced seizure activity in the sensorimotor cortex of rats. Pfülgers Arch. 398:1983;310.
19. Heinemann U., Pumain R. Effects of tetrodotoxin on changes in extracellular free calcium induced by repetitive electrical stimulation and iontophoretic application of excitatory amino acids in the sensorimotor cortex of cats. Neurosci. Lett. 21:1981;8.
20. Hotson J.R., Prince D.A. Penicillin and barium-induced epileptiform bursting in hippocampal neurons. actions on Ca and K potential Ann. Neurol. 10:1981;11.
21. Jones A.W., Smith D.A.S., Watkins J.C. Structure-activity relations of dipeptide antagonists of excitatory amino acids. Neuroscience. 13:1984;573-581.
22. Karpova M.N., Pankov O., Germane S.K., Klusha V.E., Duburs G. The antiepileptic effects of the combined action of the new 1,4 dihydropyridine derivative glutapyrone with sodium valproate and phenobarbital. Biull. Eksp. Biol. Med. 116(12):1993;586-588.
23. Kryzhanovskii G.N., Karpova M.N., Abrosimov I., Pankov O., Lakinina M.V. Anticonvulsant activity of sodium valproate and various calcium antagonists during their combined use in mice. Biull. Eksp. Biol. Med. 115(3):1993;231-233. a.
24. Kryzhanovskii G.N., Karpova M.N., Abrosimov I. The anticonvulsive activity of the 1,4 dihydropyridine derivative ryodipine and other anticonvulsants when used in combination. Biull. Eksp. Biol. Med. 116(7):1993;15-17. b.
25. Larkin J.G., Butler E., Brodie M.J. Nifedipine for epilepsy? A pilot study. Br. Med. J. 296:1988;530-531.
26. Litchfield J.T., Wilcoxone F. A simplified method of evaluating dose effect experiments. J. Pharmac. Exp. Ther. 96:1949;99.
27. MacDonald R. L. and McLean M. J. (1986) Anticonvulsant drugs: mechanism of action. In Advances in Neurology (Edited by Delgado-Escueta A. V. et al.), Vol. 44, pp. 713-736. Raven Press, New York.
28. MacDonald R. L. and Meldrum B. S. (1989) Principles of antiepileptic drug action. In Antiepileptic Drugs (Edited by Levy R. H. et al.), Vol. 4, pp. 59-83. Raven Press, New York.
29. McLean M.J., MacDonald R.L. Multiple actions of phenitoine on mouse spinal cord neurons in cell culture. J. Pharmac. Exp. Ther. 227:1983;779-789.
30. McLennan H. Receptors for excitatory amino acids in the mammalian central nervous system. Prog. Neurobiol. 20:1983;251-271.
31. Meyer F.B., Tally P., Anderson R.E., Sundt T.M., Yaksh T.L., Sharbrough F.W. Inhibition of electrically induced seizures by a dihydropyridine calcium channel blocker. Brain Res. 384:1986;180.
32. Overweg J., Binnie C.D., Meijer J.N.A., Meinardi H., Nuijten S.T.M., Schmaltz S., Wanquier A. Double-blind placebo-controlled trial of flunarizine as add-on therapy in epilepsy. Epilepsia. 25:1984;217.
33. Overweg J., Ashton D., de Beukelaar F., Binnie C.D., Wanquier A. Add-on therapy in epilepsy with calcium entry blockers. Eur. Neurol. 25(Suppl. 1):1986;93-101.
34. Özyazgan S., Özüner Z., Akkan A.G., Tekinşen A. Metoprolol'un findik farelerinde maksimal elektroşok nöbetine (Men) etkisi. Cerrahpaşa Tip Fak. Der. 23:1992;9-14.
35. Palmer G.C., Stagnitto M.L., Ray R.K., Knowles M.A., Harvey R., Garske G.E. Anticonvulsant properties of calcium channel blockers in mice. N-methyl-D-L-aspartate and BAY k-8644-induced convulsions are potently blocked by the dihydropyridines Epilepsia. 34(2):1993.
36. Pumain R., Kurcewicz I., Louvel J. Fast extracellular calcium transients. involvement in epileptic processes Science. 222:1983;177.
37. Schefield P.R., Darlison M.G., Fujita N., Burt D.R., Stephenson F.A., Rodriguez H., Glencorse T.A., Seeburg P.H., Barnard E.A. Sequence and functional expression of the GABA-A receptor shows a ligand-gated receptor super-family. Nature. 328:1987;221-227.
38. Schwartz A. Molecular and cellular aspects of calcium channel antagonism. Am. J. Cardiol. 70:1992;6F-8F.
39. Shelton R., Grebb J.A., Freed W. Induction of seizures in mice by intracerebroventricular administration of the calcium channel agonist BAY K-8644. Brain Res. 402:1987;399.
40. Sills G.J., Carswell A., Brodie M.J. Dose-response relationship with nimodipine against electroshock seizures in mice. Epilepsia. 35:1994;437-442.
41. Swinyard E.A., Brown W.C., Goodman L.S. Comparative assays of epileptic drugs in mice and rats. J. Pharmac. Exp. Ther. 106:1952;319-330.
42. Swinyard E.A., Castellion A.N., Fink G.B., Goodman L.S. Some neurophysiological and neuropharmacological characteristics of audiogenic-seizure susceptible mice. J. Pharmac. Exp. Ther. 140:1963;375-384.
43. Tsien R.W., Lipscombe D., Madison D.V., Bley K.R., Fox A.P. Multiple types of neuronal calcium channels and their selective modulation. Trends Neurosci. 11:1988;431-438.
44. Van-Luijtelaar E.L., Ateş N., Coenen A.M. Role of L-type calcium channel modulation in nonconvulsive epilepsy in rats. Epilepsia. 36:1995;86-92.
45. Vezzani A., Wu H.Q., Stasi M.A., Angelico P., Samaniu R. Effect of various calcium channel blockers on three different models of limbic seizures in rats. Neuropharmacology. 27:1988;451.
46. Watkins J.C., Evans R.H. Excitatory amino acid transmitters. Ann. Rev. Pharmac. Toxicol. 21:1981;165-204.